Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant vs Zolpidem on Postural Stability in Healthy Elderly
NCT03008447Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lemborexant in Insomnia (4 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Change from time-matched baseline in postural stability. Started Nov 2016; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03008447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008447.